Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Regenerative Medicine 2020

Regenerative Medicine 2020

About Conference


Conference Series LLC Ltd is a renowned organization that organizes highly notable conferences around the world. Regenerative Medicine 2020 welcomes all the associates around the globe which is going to be held during May 29-30, 2019 in London, UK.

Regenerative Medicine 2020 welcomes the researchers and developers, professionals who are studying or analyzing in the fields of Stem Cell, Genetics, Regenerative Medicine, Cell Biology, etc., and other associated organizations to participate in the event and grasp knowledge about the recent researches regarding stem cell and regenerative medicine and their analysis. This conference will consist of the keynote talks, session talks, oral presentations, poster presentations, B2B networking etc. The aim of this global conference is to promote the recent advances in Stem Cell Therapy Research with its applications as well as the cell and gene therapy which stands as the new therapeutic approaches. The conference will also support and motivate the young researches in the fields of Stem Cells and Genetics Research to meet the new advancements.

Why to Attend:

Regenerative Medicine 2020 is a global platform to discuss and learn about Stem Cell Research, Regenerative Medicine its Current therapies and future research directions. The Conference includes B2B Meetings, Panel Discussions, Industry expert interactions, Roundtable meetings, Best Poster awards, and Best Oral presentation awards, Young Researcher Forums, e-Poster presentations, Video presentations by the experts from both Industry & Academic.

Target Audience 

  • Gene Therapy Scientists
  • Stem Cell Researchers, developers and Investigators
  • Emeritus and Academic professors
  • Cell Biologists
  • Genetic scientists
  • Molecular Biologists
  • Regenerative Medicine researchers
  • Business Entrepreneurs
  • Drug Manufacturing Companies
  • Stem cell Developers and Investigators
  • Tissue Engineers
  • Wound care Specialists
  • Academic Professionals
  • Anatomical Researchers
  • Oncologists
  • Neurologists
  • Immunologists
  • Ophthalmologists

 

Sessions & Tracks

Track 1: Regenerative Medicine and Cell Therapy

Cell therapy and tissue engineering, which involve collecting cells from either the patient or a donor and introducing them into injured tissues or organs, sometimes after modifying their properties, offer promising solutions for regenerative medicine. Indeed, so promising are these therapies that current research has shifted from organ growth to cell therapy. The range of therapeutic applications is wide, including cardiac insufficiency, atherosclerosis, cartilage defects, bone repair, burns, diabetes and liver or bladder regeneration.

Track 2: Cell and tissue therapy in regenerative medicine

The objective of cell therapy is to restore the lost function rather than produce a new organ, which could cause duplicity and undesirable effects. Several resources of cells can be used to restore the damaged tissue, such as resident stem cells, multi potent adult progenitor cells or embryonic stem cells.

Track 3: Tissue Engineering

Tissue engineering is the use of a combination of cells, engineering, and materials methods, and suitable biochemical and physicochemical factors to improve or replace biological tissues. Tissue engineering involves the use of a tissue scaffold for the formation of new viable tissue for a medical purpose.

Track 4: Regenerative Medicine and Disease Therapeutics

Stem Cells applications in Regenerative Medicine and Disease Therapeutics is the most recent and emerging branch of medical science, deals with functional restoration of tissues or organs for the patient suffering from severe injuries or chronic disease.

Track 5: Regenerating Human Cells

Regeneration means the regrowth of a damaged or missing organ part from the remaining tissue. As adults, humans can regenerate some organs, such as the liver. If part of the liver is lost by disease or injury, the liver grows back to its original size, though not its original shape.

Track 6: Embryonic stem cells

Embryonic stem cells (ESCs) are stem cells derived from the undifferentiated inner mass cells of a human embryo. Embryonic stem cells are pluripotent, meaning they are able to grow (i.e. differentiate) into all derivatives of the three primary germ layers: ectoderm, endoderm and mesoderm.

Track 7: Tissue Regeneration using Nanotechnology

Nanotechnology is a powerful strategy in tissue regeneration for recreating the nanoscale features of tissues that can direct cellular adhesion, migration, and differentiation.

Track 8: Stem Cell

A stem cell is a cell with the unique ability to develop into specialised cell types in the body. In the future they may be used to replace cells and tissues that have been damaged or lost due to disease.

Track 9: Medical Devices and Artificial Organs

Improved health care has resulted in an increased life span for the general population and, when coupled with a growing shortage of donor organs, makes it clear that organ assistance and substitution devices will play a larger role in managing patients with end-stage disease by providing a bridge to recovery or transplantation. (In the U.S. alone, the annual need for organ replacement therapies increases by about 10 percent each year.)The good news is that the field of medical device and artificial organ development is redefining what is believed to be possible for augmenting or replacing organ function.

Track 10: Clinical Trials on Regenerative Medicine

After many years of basic research, regenerative medicine is now beginning to represent a valuable tool to cure several clinical conditions in both acute injuries and chronic diseases. The aim of this study is to update current clinical applications of some selected organs and pathologies which may benefit from regenerative medicine.


Track 11: Stem Cell Transplants for Cancer Treatment

Stem cell transplants are procedures that restore blood-forming stem cells in people who have had theirs destroyed by the very high doses of chemotherapy or radiation therapy that are used to treat certain cancers. Blood-forming stem cells are important because they grow into different types of blood cells.

Track 12: Biomaterials and Stem Cells in Regenerative Medicine

Biomaterials and Stem Cells in Regenerative Medicine explore a range of applications for biomaterials and stem cell therapy and describes recent research on suitable cell scaffolds and substrates for tissue repair and reconstruction.

Track 13: Formation of 3D Printing of Bio materials

The ability to build patient specific implants incorporated with bioactive drugs, cells, and proteins has made 3D printing technology revolutionary in medical and pharmaceutical fields. A vast variety of biomaterials are currently being used in medical 3D printing, including metals, ceramics, polymers, and composites. With continuous research and progress in biomaterials used in 3D printing, there has been a rapid growth in applications of 3D printing in manufacturing customized implants, prostheses, drug delivery devices, and 3D scaffolds for tissue engineering and regenerative medicine. 

Track 14: Embryonic Stem Cells

Embryonic stem cells are stem cells derived from the undifferentiated inner mass cells of a human embryo. Embryonic stem cells are pluripotent that means they are able to grow into all derivatives of the three primary germ layers: ectoderm, endoderm and mesoderm.

Track 15: Stem Cells capable of repairing skull, face bones

Scientists may be one step closer to a breakthrough that uses stem cells to replace damaged skull and facial bones in patients who experience a head trauma or undergo cancer surgery requiring repair and reconstructive surgery. Their finding shows that stem cells involved in skull formation are contained within this cell population. These cells are specific to the bones in the head and are very different from other stem cells involved in the formation of the bones in the legs and other parts of the body. Tests to uncover these cells could also help physicians detect bone diseases caused by stem cell abnormalities, according to the researchers.

Track 16: Recent advances in stem cell biology

A variety of stem cells with different origins and differentiation potency are expected to cure numerous degenerative diseases, chronic diseases and acute tissue injuries. Recent advances in stem cell biology and stem cell engineering provide new avenue for pluripotent stem cells, including embryonic stem cells, induced pluripotent stem cells, and directly converted stem-like cells, which are essential resources for disease modeling, drug screening, and cell therapeutics for regenerative medicine.

Track 17: Anti-aging medicine role of stem cells

Anti-aging medicines are unique because they use a patient's own stem cells and can be transplanted where they are needed. Treatments replenish the body with a fresh supply of concentrated stem cells to allow the repair and rejuvenation process in all organs, including skin.

 

Market Analysis

Global Stem Cell & Regenerative Medicine Market is expected to grow at a significant pace in future. A number of factors such as increasing disease incidence rates across the globe for diabetes, cardio-vascular diseases such as stroke, hypertension, etc., cancers that are difficult to treat and/or recover from post treatment, neurodegenerative diseases such Parkinson's disease, Alzheimer’s Disease etc., along with a rising geriatric population have resulted in an increasing demand for more efficient therapeutic strategies, one of which is stem cell therapy for regenerative medicine.

On the basis of regional platform, global stem cell and regenerative medicine market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North-America holds the highest shares in global stem cell and regenerative medicine market followed by Europe due to growth and expansion of pharmaceutical industry in the region. Globally, Asia Pacific is expected to see highest compound annual growth rate and is showcasing huge potential for the stem cell manufacturers to expand and strengthen their business in the region. This is due to the highest population along with increasing rate of cost efficient therapies in this region compared to the rest of the world. This rapid growth is mostly due to escalation of medical tourists from Europe & America who are attracted by lower prices for procedures, highly skilled medical professionals & smaller waiting list in countries such as China & India

The worldwide Stem cell & regenerative medicines market is functional with several parameters like product type, application, sources, geography and users.  In focused to the product type stem cells market is divided into human embryonic stem cells, adult stem cells, IPsec’s, etc. Whereas, regenerative medicines applied the potential of these stem cells to regenerate, repair & replace tissues or the organ which are affected due to injury, natural aging process, and some diseases.

These novel approaches are able to restore the performance of cells & tissues and applied in broad range of fields starting form Tissue Engineering to cosmetic surgery therefore, now it seeks the central attraction of researchers to focuses on the new technologies like Utilization of Nano-materials in immunomodulation, drug delivery to make the growth in regenerative medicines market and blend it with stem cell culture to open new insights, possibilities which can bring evolution in the field of medicine.

Raw Material Analysis for stem cell Market

The regenerative medicine market is broadly divided into three categories namely biologically derived materials, synthetic materials, and genetically engineered materials. The Synthetic materials and genetically engineered materials have high demands in the market due to its higher efficiency as compared to other naturally derived materials. Synthetic materials have used hydrogel in tissue engineered scaffolds.  While Genetically Engineered materials designed in vitro condition with desired gene and potentials. Financially investment for Stem cell and Regeneration Medicine are done by private inventors, and publicly traded stock as well as Government as these research holds the Possibility to Treat numerous Number of Diseases.

Cosmeceuticals Market:

Stem cell Culture Is also used in the field of Plastic and Cosmetic surgery to Remove wrinkles and different ageing issue .As these market is associated with fiction world it will contribute a good amount in the economy and growing rapidly .The market was evaluated at $42.24 billion in 2016 and is expected to reach a value of $68.72 billion by 2022, witnessing a CAGR of 8.52% during the predicted period, 2017-2022.

Cosmeceuticals are the emerging market and so there are lots of opportunities lies in the market that is needed to be explored. North America has been declared as the second largest in the market of cosmeceuticals that has estimated for a share of 31% approx. in 2016.

The United States is the major industry for the organic and in North America natural cosmetic products which shares 85% approx. in 2016 with a market value of $10.62 billion. Whereas, the Asia Pacific is the third largest industry for skin care products market which estimated a share of 22% approx. in 2016.

Market Study of Stem Cells & Regenerative Medicine:

Europe: The regenerative medicine & stem cells market is expected to reach USD 13.578 billion by 2022 from USD 5.06 billion in 2016 at a CAGR of 21.80% during the period 2016-2022.

Middle East: The regenerative medicines market is expected $ 40.55 billion revenue in 2022 from $ 17.03 billion revenue in 2016.

USA: The regenerative medicine & stem cell market is assuming to reach $38.70 billion by the year 2022 from $ 13.33 billion in 2016 at a CAGR of 23.56%.

 

To Collaborate Scientific Professionals around the World

Conference Date May 29-30, 2020

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

Journal of Molecular Biomarkers & Diagnosis Journal of Tissue Science & Engineering Journal of Molecular and Genetic Medicine

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by